FormFactor shares surpass Wall Street target as HBM4 demand outlook strengthens
AI Summary- FormFactor shares have exceeded Wall Street analysts’ average price target.
- Analysts cite expanding test demand tied to the HBM4 transition.
- FormFactor maintains a close partnership with South Korea’s SK Hyni.